Enterprise Value to EBITDA Multiple ratio Analysis of Acasti Pharma Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY EV to EBITDA
Period Ending - Mar-23

0.623


Excellent EV to EBITDA
Period Ending - Mar-22
0.686

Excellent EV to EBITDA
Growth
-9.28 %
Trailing Twelve Months EV to EBITDA
Period Ending - Mar-23

0.135


Excellent EV to EBITDA
EV to EBITDA Analysis of Acasti Pharma Inc
Enterprise Value to EBITDA 0.623 of Acasti Pharma Inc indicate that a company is more attractive or undervalued in the market.
EV to EBITDA Ratio of ACST has fallen by -9.28 % Compared to previous Financial Year.
EV to EBITDA Ratio with value of 4.44 was highest in Year Mar-21 in last Five Years.
EV to EBITDA Ratio with value of 0.402 was lowest in Year Mar-19 in last Five Years.
Latest EV to EBITDA Ratio with value of 0.623 is lower than Average EV to EBITDA of 1.32 in last five years.
Other EV to EBITDA Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
CodePricePrevious PricePrice ChangeSector
ACST2.692.7599 2.53 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued.    more ..
Enterprise Value to EBITDA Multiple Formula
EV to EBITDA Related Ratios
EBITDAMarginEVToRevenuePriceToEarningRatio
Tsr Value Index
Poor Value Stock
FY - Historical Enterprise Value to EBITDA Multiple of Acasti Pharma Inc
PeriodMar-23Mar-22Mar-21Mar-20Mar-19Mar-18Mar-17
EV to EBITDA0.6230.6864.440.4320.4020.2950.617
Change-9.28 %-84.56 %929.21 %7.34 %36.11 %-52.13 %98.87 %
You are view first 7 Records. Log in to view all 14 in Premium view
FY Chart of Enterprise Value to EBITDA Multiple of Acasti Pharma Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)